Cargando…
Drug-induced liver injury and COVID-19: A review for clinical practice
Coronavirus disease 2019 (COVID-19) consists of a systemic disease that can present many complications. The infection presents broad clinical symptoms and a high rate of transmissibility. In addition to severe acute respiratory syndrome, the patients manifest complications beyond the respiratory sys...
Autores principales: | Ortiz, Gabriela Xavier, Lenhart, Gabriele, Becker, Matheus William, Schwambach, Karin Hepp, Tovo, Cristiane Valle, Blatt, Carine Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473488/ https://www.ncbi.nlm.nih.gov/pubmed/34630881 http://dx.doi.org/10.4254/wjh.v13.i9.1143 |
Ejemplares similares
-
Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence?
por: Becker, Matheus William, et al.
Publicado: (2021) -
Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023) -
Nutritional evaluation in cirrhosis: Emphasis on the phase angle
por: Fernandes, Sabrina Alves, et al.
Publicado: (2016) -
Role of immune dysfunction in drug induced liver injury
por: Girish, Chandrashekaran, et al.
Publicado: (2021) -
Drug-induced liver injury: Towards early prediction and risk stratification
por: Raschi, Emanuel, et al.
Publicado: (2017)